Investor Incyte Corp
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Incyte Corp . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2024-07-24 13G/A MRUS / Merus N.V. 4,004,544 1,008,076
2024-03-25 13G MRUS / Merus N.V. 4,004,544 4,004,544
2023-08-14 13D/A MRUS / Merus N.V. 3,550,000 4,004,544
2023-02-08 13G/A CALA / Calithera Biosciences, Inc. 1,720,430 0
2022-02-11 13G/A AGEN / Agenus Inc. 14,062,227 12,070,195
2021-02-11 13G/A AGEN / Agenus Inc. 17,763,968 14,062,227
2021-01-25 13D/A MRUS / Merus N.V. 3,200,000 3,550,000
2020-12-28 13D MRUS / Merus N.V. 3,200,000 3,200,000
2017-02-14 13G/A AGEN / Agenus Inc. 17,763,968
2017-01-31 13G CALA / Calithera Biosciences, Inc. 1,720,430
2017-01-23 13G MRUS / Merus N.V. 3,200,000
2015-02-20 13G AGEN / Agenus Inc. 7,763,968